Medicare Enrolled

Dr. Paul Gittelman, M.D.

Otolaryngology · Purchase, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3020 WESTCHESTER AVE, Purchase, NY 10577
9146076501
In practice since 2006 (19 years)
NPI: 1689761686 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gittelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gittelman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gittelman

Dr. Paul Gittelman is an otolaryngology specialist in Purchase, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gittelman performed 2,745 Medicare services across 1,810 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gittelman received a total of $5,493 from 30 pharmaceutical and/or device companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in otolaryngology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gittelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in NY $5,493 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,745
Medicare services
Top 12% in NY for otolaryngology
1,810
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~144 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
719 $118 $225
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
621 $34 $293
Nasal endoscopy
A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages.
489 $178 $766
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
298 $76 $217
Impacted earwax removal by physician
Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing.
247 $40 $109
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
85 $90 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $157 $360
Middle ear function test
A diagnostic test used to evaluate how well the middle ear is functioning.
70 $15 $63
Microscopic ear examination
A detailed visual inspection of the ear using a specialized microscope to examine the ear canal and eardrum.
69 $27 $65
Flexible laryngoscopy
A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx.
54 $119 $290
Strep A rapid test
A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation.
22 $16 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,493
Total received (2018-2024)
Avg $785/year across 7 years
Top 15% in NY for otolaryngology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
269
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,493 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$828
2023
$1,519
2022
$891
2021
$365
2020
$519
2019
$860
2018
$511

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$318
GENZYME CORPORATION
$177
GlaxoSmithKline, LLC.
$72
CSL Behring
$70
AstraZeneca Pharmaceuticals LP
$63
Optinose US, Inc.
$46
Inspire Medical Systems, Inc.
$27
kaleo, Inc.
$20
Hikma Pharmaceuticals USA
$19
Stryker Corporation
$15
Top 3 companies account for 68.5% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$910
GlaxoSmithKline, LLC.
$827
Novartis Pharmaceuticals Corporation
$824
OptiNose US, Inc.
$380
AstraZeneca Pharmaceuticals LP
$355
Optinose US, Inc.
$323
CSL Behring
$234
ARBOR PHARMACEUTICALS, INC.
$213
Acclarent, Inc
$173
Shire North American Group Inc
$150
Takeda Pharmaceuticals U.S.A., Inc.
$148
Regeneron Healthcare Solutions, Inc.
$137
ALK-Abello, Inc
$132
kaleo, Inc.
$105
Intersect ENT, Inc.
$87
Hikma Pharmaceuticals USA
$86
Stryker Corporation
$84
Inspire Medical Systems, Inc.
$68
Blueprint Medicines Corporation
$30
Medtronic, Inc.
$30
Mylan Specialty L.P.
$29
Kaleo, Inc.
$23
Genentech USA, Inc.
$22
Pharming Healthcare, Inc.
$21
Grifols USA, LLC
$21
Amgen Inc.
$20
Merck Sharp & Dohme LLC
$19
PFIZER INC.
$19
Glenmark Therapeutics Inc.
$14
Smith & Nephew, Inc.
$11
Top 3 companies account for 46.6% of all-time payments
Associated products mentioned in payments ›
ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM · ACCLARENT Balloon Inflation Device · AUVI-Q · AYVAKIT · CUVITRU · Coblation - Tonsil Wands · DUPIXENT · Dymista · ENTELLUS - XPRESS ENT DILATION SYSTEM · EUCRISA · FASENRA · GAMMA · HYQVIA · Hizentra · INSPIRE · NUCALA · Odactra · Otiprio · Otovel · PAZEO · PROPEL · RUCONEST · Ryaltris · SCOPIS ENT · Sinuva · TRELEGY ELLIPTA · TruDi Navigation System · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an otolaryngology specialist in Purchase?
Compare otolaryngologists in the Purchase area by procedure volume, costs, and industry payment transparency.
Browse otolaryngologists nearby

Geographic Context

Otolaryngologists within 10 mi
412
Per 100K population
41.3
County median income
$118,411
Nearest hospital
WHITE PLAINS HOSPITAL CENTER
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gittelman is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NY), with low-engagement industry engagement in the top 15% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gittelman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gittelman performed 719 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gittelman receive payments from pharmaceutical companies?
Yes. Dr. Gittelman received a total of $5,493 from 30 companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gittelman's costs compare to other otolaryngologists in Purchase?
Dr. Gittelman's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gittelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →